| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/14/2000 | EP1007535A1 Methods and compositions for diagnosis and treatment of breast cancer |
| 06/14/2000 | EP1007534A1 Bh3 interacting domain death agonist |
| 06/14/2000 | EP1007533A1 Bioconjugates and delivery of bioactive agents |
| 06/14/2000 | EP1007099A1 Method of inducing apoptosis by reducing the level of thiamin |
| 06/14/2000 | EP1007095A2 Chimeric toxins for targeted therapy |
| 06/14/2000 | EP1007093A1 Methods for treating disorders by using interleukin-9 and its antagonists |
| 06/14/2000 | EP1007092A1 A process for inhibiting complement activation via the alternative pathway |
| 06/14/2000 | EP1007091A1 Sr-bi antagonists and use thereof as contraceptives and in the treatment of steroidal overproduction |
| 06/14/2000 | EP1007090A1 Identification of unique binding interactions between certain antibodies and the human b7.1 and b7.2 co-stimulatory antigens |
| 06/14/2000 | EP1007089A1 Anticoagulant agents useful in treatment of thrombosis |
| 06/14/2000 | EP1007086A1 Use of lactoperoxidase, a peroxide donor and thiocyanate for the manufacture of a medicament for treating helicobacter pylori infection |
| 06/14/2000 | EP1007085A1 Use of growth hormone in compositions for treating insulin resistance in the heart and for enhancing protein kinase b (pkb) activity |
| 06/14/2000 | EP1007084A1 Immunogenic lhrh compositions and methods relating thereto |
| 06/14/2000 | EP1007083A1 Stabilisation of interferons in aqueous solution for manufacture of sublingually administered tablets |
| 06/14/2000 | EP1007082A1 Modified tumor necrosis factor |
| 06/14/2000 | EP1007080A1 Sustained peptide-release formulation |
| 06/14/2000 | EP1007079A1 Identification of broadly reactive dr restricted epitopes |
| 06/14/2000 | EP1007078A1 Peptidomimetics containing 6-peptidylamino-1-naphthalenesulfonamide moieties |
| 06/14/2000 | EP1007077A1 Compounds and their combinations for the treatment of influenza infection |
| 06/14/2000 | EP1007076A1 Method of antagonizing the human src sh2 domain |
| 06/14/2000 | EP1007075A1 Structurally modified peptides resistant to peptidase degradation |
| 06/14/2000 | EP1007074A1 Hypothalamus-specific polypeptides |
| 06/14/2000 | EP1007073A1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) |
| 06/14/2000 | EP1007072A1 Glial cell line-derived neurotrophic factor receptors |
| 06/14/2000 | EP1007071A1 Methods of treating renal disease with a gastrin releasing peptide receptor antagonist |
| 06/14/2000 | EP1007070A1 Prolonging survival of transplanted pancreatic cells |
| 06/14/2000 | EP1007069A1 Novel coding sequences |
| 06/14/2000 | EP1007068A1 Process for preparing synthetic soil-extract materials and medicaments based thereon |
| 06/14/2000 | EP1007065A1 Preparation of collagen |
| 06/14/2000 | EP1007064A1 Regeneration of nerves in the central nervous system |
| 06/14/2000 | EP1007062A1 Therapeutic use of hemoglobin to treat head injury |
| 06/14/2000 | EP1007048A1 Identification of agents for use in the treatment of alzheimer's disease |
| 06/14/2000 | EP1007034A1 Compositions containing bergamottin for increasing the oral bioavailability of pharmaceutical agents |
| 06/14/2000 | EP1007022A1 Preparation of a pulmonary surfactant for instillation and oral application |
| 06/14/2000 | EP1007000A2 Stable particle in liquid formulations |
| 06/14/2000 | EP1006798A1 Compositions and methods for treatment of neurological disorders and neurodegenerative diseases |
| 06/14/2000 | EP1006794A1 A method for treating or preventing alzheimer's disease |
| 06/14/2000 | EP1006785A1 Antimicrobial proteins |
| 06/14/2000 | EP0901463B1 Glycerolipidic compounds used for the transfer of an active substance into a target cell |
| 06/14/2000 | EP0754193B1 Hepatitis c virus core peptide for stimulation of cytotoxic t lymphocytes and diagnosis of hcv exposure |
| 06/14/2000 | EP0710243B1 Synthesis of cyclic peptides |
| 06/14/2000 | EP0693932A4 Methods and compositions for inducing phase separation of epithelial lipid bilayers |
| 06/14/2000 | EP0677057B1 Biopolymer synthesis utilizing surface activated, organic polymers |
| 06/14/2000 | EP0667785B1 Method of treating non-streptococcal bacterial infections |
| 06/14/2000 | CN1256700A Biodegradable terephthalate polyester-poly(phosphate) polymers, compositions, articles,and method for making and using the same |
| 06/14/2000 | CN1256696A Monoclonal antibody which recognizes the oligosaccharide N-glycolylated-galactose-glucose sialic acid in malignant tumors, and composition containing it |
| 06/14/2000 | CN1256695A Synthetic peptides useful in biological assays for detecting infections caused by group O HIV-1 viruses |
| 06/14/2000 | CN1256632A Suppression of malignancy utilizing ribonucleotide reductase R1 |
| 06/14/2000 | CN1256628A Sustained-release compositions and method for preparing same |
| 06/14/2000 | CN1256626A Stable particle in liquid formulations |
| 06/14/2000 | CN1256307A Scorpion-ant wine making process and formulation |
| 06/14/2000 | CN1256151A Preparation of multiepitope epitope vaccine |
| 06/14/2000 | CN1256150A Preparation of epitope vaccine with single monoepitope or multiple monoepitope duplication |
| 06/14/2000 | CN1256149A Preparation of dissociation-resisting epitope vaccine |
| 06/14/2000 | CN1256148A Stable water solution of interferon |
| 06/14/2000 | CN1053451C Novel peptide compound with therapeutic active in blood coagulation reaction, its prep. and pharmaceutical composition thereof |
| 06/14/2000 | CN1053320C Use of micellar casein of butter milk |
| 06/13/2000 | US6075183 Nucleic acid construct for production of fatty acids and a desaturase in edible plant tissues and/or plant parts such as leaves, roots, fruits and seeds |
| 06/13/2000 | US6075150 A cell antiproliferative agent |
| 06/13/2000 | US6075137 Polynucleotide sequence coding polypeptide; for diagnosis and treatment of heart defects, hypotension, hypertension, angina pectoris, ulcers, psychotic and neurological disorders; for detecting agonist and antagonist of protein |
| 06/13/2000 | US6075136 Polynucleotide sequence coding a polypeptide with enzymatic activity; for treating or preventing cancer and reproductive defects; anticarciongenic agents |
| 06/13/2000 | US6075129 Anticoagulent peptide; for use in inhibiting or facilitating inhibition of platelet aggregation |
| 06/13/2000 | US6075128 Materials and methods for isolating IgA immunoglobulins |
| 06/13/2000 | US6075124 Mammalian polypeptide for the prevention and treatment of arthritis, lung inflammation, allergies, parasitic infections, inflammation, atherosclerosis and tumors; to promote wound healing and to regulate hematopoiesis |
| 06/13/2000 | US6075123 Cyclin-C variants, and diagnostic and therapeutic uses thereof |
| 06/13/2000 | US6075122 A peptide for the detection, monitoring, and treatment of cancer in animals; anticarciongenic agents |
| 06/13/2000 | US6075121 Modified peptide and peptide libraries with protease resistance, derivatives thereof and methods of producing and screening such |
| 06/13/2000 | US6075120 Bradykinin antagonist |
| 06/13/2000 | US6075119 Particles useful in the prevention and treatment of staphylococcal or streptococcal infection |
| 06/13/2000 | US6075031 Use of creatine analogues and creatine kinase modulators for the prevention and treatment of glucose metabolic disorders |
| 06/13/2000 | US6075020 Method of regulating immune function |
| 06/13/2000 | US6075009 Neuropeptide Y analogues, compositions and methods of lowering blood pressure |
| 06/13/2000 | US6075008 Method for promoting cell proliferation and growth |
| 06/13/2000 | US6075007 Modified noggin polypeptide and compositions |
| 06/13/2000 | US6075006 For treatment of arthritis, asthma, inflammation, tumoral growth, gastro intestinal hypermotility, huntington disease, neuritis, neuralgia, migraine, hypertension, incontinence of urine, urticaria, symptoms of the carcinoid syndrome |
| 06/13/2000 | US6075005 Medicaments comprising relaxin and their use |
| 06/13/2000 | US6075004 Peptide compositions which induce immune tolerance and methods of use |
| 06/13/2000 | US6074875 Materials and methods relating to the regulation of polypeptide production in cells |
| 06/13/2000 | US6074873 Nucleic acids encoding NL-3 |
| 06/13/2000 | US6074872 Nucleic acid sequence coding a nervous system polypeptide; for inducing sleep in mammals and the treatment of sleep defects; for screening potential modulators of sleep |
| 06/13/2000 | US6074864 Spodoptera insect cell transformed by a vector coding a cerebroside enzyme for treating gaucher's disease |
| 06/13/2000 | US6074862 Enzymatic polypeptide that stimulates phosphorylation of kinase; for the treatment of inflammation, autoimmune diseases and cancer; anticarcinogenic agents; bactericides |
| 06/13/2000 | US6074861 Protein with enzymatic activity; for the treatment of inflammation and cancer, nervous system, allergies and autoimmune defects; antiinflammatory agents; anticarcinogenic agents |
| 06/13/2000 | US6074852 Producing mannose-terminated protein by culturing host cell transformed with gene from e1 or e2 region, causing expression but inhibiting sialylation, isolating glycoprotein using mannose-binding protein |
| 06/13/2000 | US6074849 Polynucleotides encoding human CTLA-8 related proteins |
| 06/13/2000 | US6074848 Amino acid sequence; for antiproliferative and wound healing agents |
| 06/13/2000 | US6074846 Hepatitis C virus asialoglycoproteins |
| 06/13/2000 | US6074844 Polynucleotides encoding human membrane fusion proteins |
| 06/13/2000 | US6074843 Amino acid and nucleotide sequences of gene involved in controlling transcription; for diagnosis, prevention, and treatment of respiratory, developmental, and nervous system disorders; for antisense agents |
| 06/13/2000 | US6074841 Don-1 gene and polypeptides and uses therefor |
| 06/13/2000 | US6074840 Recombinant production of latent TGF-beta binding protein-3 (LTBP-3) |
| 06/13/2000 | US6074839 Transforming growth factor αHI |
| 06/13/2000 | US6074828 Screening compounds by transforming cell with recombinant expression contruct which expresses excitatory amino acid transporter and analyzing cell to determine if compound binds to transporter |
| 06/13/2000 | US6074821 CDNA for human methylenetetrahydrofolate reductase |
| 06/13/2000 | US6074689 Colonic delivery of protein or peptide compositions |
| 06/13/2000 | US6074671 Method of using lectins for contraception and prophylaxis against diseases transmittable by sexual contact and condom containing lectins |
| 06/13/2000 | US6074664 Foil or flat shaped |
| 06/13/2000 | US6074650 Membrane anchor/active compound conjugate, its preparation and its uses |
| 06/13/2000 | US6074645 Immuno-reactive peptide CTL epitopes of human cytomegalovirus |
| 06/13/2000 | US6074644 Cytotoxic activity |